Viewing Study NCT06539559


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-02-03 @ 3:18 AM
Study NCT ID: NCT06539559
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-06
First Post: 2024-07-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
Sponsor: Wang Jiayu
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module